These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 3768313

  • 1. 3-(Trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine photolabels a substrate-binding site of rat hepatic cytochrome P-450 form PB-4.
    Frey AB, Kreibich G, Wadhera AB, Clarke L, Waxman DJ.
    Biochemistry; 1986 Aug 26; 25(17):4797-803. PubMed ID: 3768313
    [Abstract] [Full Text] [Related]

  • 2. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
    Haaparanta T, Halpert J, Glaumann H, Gustafsson JA.
    Cancer Res; 1983 Nov 26; 43(11):5131-7. PubMed ID: 6413054
    [Abstract] [Full Text] [Related]

  • 3. Purification and partial characterization of hepatic microsomal cytochrome P-450s from phenobarbital- and 3-methylcholanthrene-treated rats.
    Masuda-Mikawa R, Fujii-Kuriyama Y, Negishi M, Tashiro Y.
    J Biochem; 1979 Nov 26; 86(5):1383-94. PubMed ID: 118169
    [Abstract] [Full Text] [Related]

  • 4. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography.
    Imaoka S, Inoue K, Funae Y.
    Arch Biochem Biophys; 1988 Aug 15; 265(1):159-70. PubMed ID: 3415241
    [Abstract] [Full Text] [Related]

  • 5. Different patterns of benzo[a]pyrene metabolism of purified cytochromes P-450 from methylcholanthrene, beta-naphthoflavone and phenobarbital treated rats.
    Gozukara EM, Guengerich FP, Miller H, Gelboin HV.
    Carcinogenesis; 1982 Aug 15; 3(2):129-33. PubMed ID: 6279326
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
    Mays DC, Hilliard JB, Wong DD, Chambers MA, Park SS, Gelboin HV, Gerber N.
    J Pharmacol Exp Ther; 1990 Aug 15; 254(2):720-31. PubMed ID: 2117068
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
    Malejka-Giganti D, Decker RW, Ritter CL, Polovina MR.
    Carcinogenesis; 1985 Jan 15; 6(1):95-103. PubMed ID: 3967341
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Purification and characterization of cytochrome P450 isozymes from beta-naphthoflavone-induced adult hen liver.
    Gupta RP, Lapadula DM, Abou-Donia MB.
    Arch Biochem Biophys; 1990 Oct 15; 282(1):170-82. PubMed ID: 2171427
    [Abstract] [Full Text] [Related]

  • 16. Modifications of carcinogen metabolism in hepatic microsomes of suckling young by 3-methylcholanthrene or beta-naphthoflavone administered to lactating rats.
    Malejka-Giganti D, Decker RW, Ritter CL.
    Biochem Pharmacol; 1983 Nov 15; 32(22):3335-44. PubMed ID: 6316979
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.